Skip to content
★ Sign in to follow
SP

Singapore Paincare Holdings Limited Stock: price and insider trades · Singapore

ISIN SGXE51400773SG·Mcap SGD 11.1MHealth Care

No insider purchase over the last 90 days. The latest, by LOH FOO KEONG JEFFREY, was filed 19 Dec 2022.

Singapore Paincare Holdings Limited: what insiders have been doing

Singapore Paincare Holdings Limited, classified in the Health Care sector, is a listed company. Its insiders report their share dealings to SGX. Nothing new has been filed by managers of Singapore Paincare Holdings Limited in twelve months, the latest record being from 30 December 2022.

Since 2020, the database holds 8 purchases and 3 sales by insiders of the company.

Elsewhere in the same sector, our signals recently picked up insider purchases at Dynavox Group AB and EssilorLuxottica. Source: insider filings from SGX. Past trades are no guide to future returns.

Insider Decl.
17
Thresholds
n/a
Buy Volume
€4M
8 ops. · all time
Sell Volume
€2M
3 ops. · all time

Since the insiders bought

  • Filed 19 Dec 2022 · 1421 days ago · €26k
    -11.0%
    Entry SGD 0.20 · Close at T+365 SGD 0.18
  • Filed 08 Apr 2022 · 1676 days ago · €29k
    +15.0%
    Entry SGD 0.20 · Close at T+365 SGD 0.23
  • Filed 01 Dec 2021 · 1804 days ago · €117k
    +5.8%
    Entry SGD 0.19 · Close at T+365 SGD 0.20

Entry is the close on the day after publication, the first price a reader could act on. Prices in the listing currency. Past moves are not a forecast.

This score ranks the purchase within its own market. A position size is suggested only on the venues of the backtested strategy universe; elsewhere, signals stay on watch. Not investment advice.

Fundamental score
Ranked 12,383 of 26,911 companies
53.6
score / 100
Value
63
Quality
44
FCF yld37%
Earn yld-7.7%
EV/EBITDA7.0x
ROE0.1%
Gross mgn78%
Net mgn-3.1%
Debt/EBITDA3.0x
Pillars2/3

Transparent value + quality ranking, distinct from the insider signal.

Financial data

as of FY 2026

FY ended June 2026 · cache

SGD 0.07
Analyst consensus
·
Income statement
RevenueSGD 27.4M
Gross profitSGD 21.4M78% margin
EBITDASGD 2.8M10% margin
Net income-SGD 858k-3.0% margin
Valuation
P/Book0.6x
Beta-0.01
Balance sheet & cash
Market capSGD 11.1M
Total debtSGD 8.5M
Free Cash FlowSGD 4.2M
Debt / Equity47%
Profitability & ownership
ROE0.1%
ROA2.2%
% insiders80.8%
% institutions0.5%
Last declaration on 30 December 2022
Declarations17 total
  • ●
    Substantial ShareholderExecutives(filed)
    0SGX
    ShareSGX-STISIN SGXE51400773SGX:VEMZB7GNTINAOEWF
  • ●
    Substantial ShareholderExecutives(filed)
    0SGX
    ShareSGX-STISIN SGXE51400773SGX:YSQDUSL3349E358A
  • ●
    Substantial ShareholderExecutives(filed)
    0SGX
    ShareSGX-STISIN SGXE51400773SGX:B3JAIS0MGA1YBZJG
  • ▲
    Director/CEOExecutives
    38,080 SGD30SGX
    193,300 shares@ SGD 0.197100.0% of flowShareSGX-STISIN SGXE51400773SGX:AEJKMBJBRBLF2KHX
    Canonical exit: 19 Mar 2023 (T+90)
  • ▲
    Substantial ShareholderExecutives(filed)
    0SGX
    2,297,000 sharesShareSGX-STISIN SGXE51400773SGX:QNNWSA9X4PZ7SP2M
    Canonical exit: 25 Dec 2022 (T+90)
  • ▲
    Director/CEOExecutives
    42,460 SGD30SGX
    193,000 shares@ SGD 0.22100.0% of flowShareSGX-STISIN SGXE51400773SGX:16AM6PSXKQ04993X
    Canonical exit: 7 Jul 2022 (T+90)
  • ▲
    Substantial ShareholderExecutives(filed)
    180,657 SGD13SGX
    950,825 shares@ SGD 0.19100.0% of flowShareSGX-STISIN SGXE51400773SGX:EKZY095HDOKVGW30
    Canonical exit: 1 Mar 2022 (T+90)
  • ▼
    Substantial ShareholderExecutives(filed)
    1M SGD28SGX
    5,657,090 shares@ SGD 0.2297.8% of flowShareSGX-STISIN SGXE51400773SGX:Z4CZQINNLYGTRW5N
  • ▼
    Substantial ShareholderExecutives(filed)
    735,440 SGD25SGX
    3,342,910 shares@ SGD 0.22100.0% of flowShareSGX-STISIN SGXE51400773SGX:MW0N9JZ78VJXTHND
  • ▼
    Related company / holdingExecutives(filed)
    1M SGD13SGX
    5,657,090 shares@ SGD 0.22100.0% of flowShareSGX-STISIN SGXE51400773SGX:ILFCU01ENDDDXX4G
  • ▲
    Substantial ShareholderExecutives(filed)
    2M SGD8SGX
    9,000,000 shares@ SGD 0.2232.0% of flowShareSGX-STISIN SGXE51400773SGX:3LI2FE9OGDHWZE5J
    Canonical exit: 4 Mar 2021 (T+90)
  • ▲
    Substantial ShareholderExecutives(filed)
    4M SGD11SGX
    18,000,000 shares@ SGD 0.2264.9% of flowShareSGX-STISIN SGXE51400773SGX:8APR0KVSB2C7JR2E
    Canonical exit: 1 Mar 2021 (T+90)
  • ●
    Related company / holdingExecutives(filed)
    0SGX
    ShareSGX-STISIN SGXE51400773SGX:QMN7HBUQ9MRL2GRV
  • ●
    Substantial ShareholderExecutives(filed)
    0SGX
    ShareSGX-STISIN SGXE51400773SGX:KH7HSWHYZ0OUDHI4
  • ●
    Substantial ShareholderExecutives(filed)
    0SGX
    ShareSGX-STISIN SGXE51400773SGX:TGX189UYPHUH7STP
  • ▲
    Substantial ShareholderExecutives(filed)
    28,650 SGD5SGX
    150,000 shares@ SGD 0.1912.2% of flowShareSGX-STISIN SGXE51400773SGX:FNUBK8BE5KI2GK9O
    Canonical exit: 13 Dec 2020 (T+90)
  • ▲
    Related company / holdingExecutives(filed)
    0SGX
    2,248,000 sharesShareSGX-STISIN SGXE51400773SGX:8OVXNGRZ8GHDA17R
    Canonical exit: 28 Oct 2020 (T+90)

17 of 17 declarations

About Singapore Paincare Holdings Limited

Singapore Paincare Holdings Limited is a company listed on the Singapore Exchange, specializing in pain management services and related treatments. It focuses on improving the quality of life for patients suffering from chronic pain.

Recent ranked signals in the same sector

Purchases our model currently ranks for the recommendations list.

All recommendations